IP Library Granted Patent US 9,393,022
Granted Patent B2
US 9,393,022 · App. 13/962,267 · Granted Jul 19, 2016

Two-stage deployment aneurysm embolization devices

Inventors: Frank P. Becking (Santa Clara, CA); Karl S. Halden (San Carlos, CA); Martin S. Dieck (Campbell, CA); Nicholas C. Debeer (Montara, CA); Teresa Ruvalcaba (Palo Alto, CA); Andre-Jean Lundkvist (Palo Alto, CA)
Assignee: Covidien LP
A61B17/12159A61B17/12113A61B17/12172A61B2017/00526A61B2017/00867A61B2017/12054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,393,022
App. No.
13/962,267
Granted
Jul 19, 2016
Kind
B2
Abstract

Embolic implants, delivery systems and methods of manufacture and delivery are disclosed. The subject implants are deployed in two stages. If sized properly as observed in the first stage, they are deployed to the second stage and detached. If not sized properly in/at the first stage, the implants are designed to be withdrawn and replaced with a more appropriately sized implant or another treatment option selected. Some of the implant configurations may be withdrawn even after the second stage deployment as well.

Claims (15)

1. An aneurysm treatment system comprising:

a catheter with a distal marker and a proximal reference marker;

an implant pusher; and

an implant connected to a distal end of the implant pusher and comprising a bulbous portion and a tail portion, the tail portion adapted to be received in a linear configuration within the catheter with a distal end of the tail portion being proximal to the bulbous portion when the implant is in an intermediate stage, the tail portion defining an inset within the bulbous portion when the implant is in a final stage,

wherein at least one of the pusher and the implant comprises an implant marker, wherein when the implant marker is aligned with the proximal reference marker, the implant is in the intermediate stage with the bulbous portion of the implant deployed from the catheter, wherein, when the implant marker is aligned with the distal marker, the implant is in the final stage with the implant deployed from the catheter and the tail portion defining the inset within the bulbous portion, wherein the implant has a height that is approximately the same in the intermediate stage and in the final stage.

2. The system of claim 1 , wherein the bulbous portion has a teardrop shape in the intermediate stage.

3. The system of claim 1 , wherein the bulbous portion has a mushroom shape in the intermediate stage.

4. The system of claim 1 , wherein the inset is configured to be recapturable in clinical use.

5. The system of claim 1 , wherein the inset is configured so that it is not recapturable in clinical use.

6. The system of claim 5 , wherein the inset is substantially spherical.

7. The system of claim 5 , wherein the inset has an opposing cone shape.

8. The system of claim 5 , wherein the inset includes an inverted hub.

9. The system of claim 5 , wherein the inset includes no hub.

10. The system of claim 9 , wherein the inset is adapted to expand from a compressed conical shape.

11. The system of claim 10 , wherein the inset is adapted to expand into the bulbous portion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: BECKING, FRANK P.; HALDEN, KARL STERLING; DEBEER, NICHOLAS C.; RVALACABA, TERESA; LUNDKVIST, ANDRE
To: COVIDIEN LP
Reel/Frame 038913/0763 →
Continuity (3)
Continuation PCTUS2012024747 · Feb 10, 2012
Provisional Application 61441845 · Feb 11, 2011
Related Publication 20140172001A1 · Jun 19, 2014